Published in Gastrointest Endosc on October 01, 2004
Circumferential intramural esophageal dissection successfully treated by endoscopic procedure and metal stent insertion. J Gastroenterol (2005) 1.36
Temporary metallic stent placement in the treatment of refractory benign esophageal strictures: results and factors associated with outcome in 55 patients. Eur Radiol (2008) 1.20
Polyflex self-expanding, removable plastic stents: assessment of treatment efficacy and safety in a variety of benign and malignant conditions of the esophagus. Surg Endosc (2007) 1.16
A comprehensive review of esophageal stents. Gastroenterol Hepatol (N Y) (2012) 1.12
Long-term safety and outcome of a temporary self-expanding metallic stent for achalasia: a prospective study with a 13-year single-center experience. Eur Radiol (2009) 1.02
A comparison of the temporary placement of 3 different self-expanding stents for the treatment of refractory benign esophageal strictures: a prospective multicentre study. BMC Gastroenterol (2012) 1.02
Dilation of benign strictures in the esophagus and colon with the polyflex stent: a case series study. Dig Dis Sci (2007) 1.01
The use of a self-expandable plastic stent for an iatrogenic esophageal perforation. Gastroenterol Hepatol (N Y) (2010) 0.97
Partially versus fully covered self-expanding metal stents for benign and malignant esophageal conditions: a single center experience. Surg Endosc (2013) 0.96
Plastic and biodegradable stents for complex and refractory benign esophageal strictures. Clin Endosc (2014) 0.96
Woven polydioxanone biodegradable stents: a new treatment option for benign and malignant oesophageal strictures. Eur Radiol (2009) 0.94
Temporary self-expanding metallic stents for achalasia: a prospective study with a long-term follow-up. World J Gastroenterol (2010) 0.92
Clinical outcomes of self-expandable stent placement for benign esophageal diseases: A pooled analysis of the literature. World J Gastrointest Endosc (2015) 0.91
Upper Gastrointestinal Stent Insertion in Malignant and Benign Disorders. Clin Endosc (2015) 0.91
Clinical outcomes after self-expanding plastic stent placement for refractory benign esophageal strictures. Dig Dis Sci (2010) 0.90
Polyflex Stent for Relief of Obstruction in a Patient With a Benign Anastomotic Colonic Stricture and Description of Nonfluoroscopic Technique. Gastroenterol Hepatol (N Y) (2006) 0.89
What is the optimal duration of stent placement for refractory, benign esophageal strictures? Nat Clin Pract Gastroenterol Hepatol (2009) 0.88
Intralesional steroid injection therapy in the management of resistant gastrointestinal strictures. World J Gastrointest Endosc (2010) 0.88
Benign strictures of the esophagus and gastric outlet: interventional management. Korean J Radiol (2010) 0.87
The use of self-expanding silicone stents in esophageal cancer care: optimal pre-, peri-, and postoperative care. Surg Endosc (2008) 0.86
Comparison between botulinum injection and removable covered self-expanding metal stents for the treatment of achalasia. Dig Dis Sci (2013) 0.84
Efficacy of Gastric Balloon Dilatation and/or Retrievable Stent Insertion for Pyloric Spasms after Pylorus-Preserving Gastrectomy: Retrospective Analysis. PLoS One (2015) 0.83
Role of stenting in gastrointestinal benign and malignant diseases. World J Gastrointest Endosc (2015) 0.82
Retrievable esophageal stents for benign indications. Dig Dis Sci (2007) 0.82
Comparison of a standard fully covered stent with a super-thick silicone-covered stent for the treatment of refractory esophageal benign strictures: A prospective multicenter study. United European Gastroenterol J (2013) 0.81
Endoscopic approach to achalasia. World J Gastrointest Endosc (2013) 0.79
Evidence-based recommendations on upper gastrointestinal tract stenting: a report from the stent study group of the korean society of gastrointestinal endoscopy. Clin Endosc (2013) 0.78
Expandable polyester silicon-covered stent for malignant esophageal strictures before neoadjuvant chemoradiation: a pilot study. Dig Dis Sci (2007) 0.78
Plastic tube-assisted gastroscopic removal of embedded esophageal metal stents: a case report. World J Gastroenterol (2013) 0.75
Total neopharyngeal stenosis following pharyngolaryngo-oesophagectomy with gastric interposition: Successful recanalisation using a transcervical radiologically guided technique. Int J Surg Case Rep (2011) 0.75
Tracheobronchial Polyflex stents for the management of benign refractory hypopharyngeal strictures. World J Gastroenterol (2012) 0.75
How do I dilate a benign esophageal stricture? Can J Gastroenterol (2006) 0.75
Self-expandable metal stenting of refractory upper gut corrosive strictures: a new role for endoscopy? Case Rep Gastrointest Med (2011) 0.75
Fully covered self-expanding metallic stent placement for benign refractory esophageal strictures. Indian J Gastroenterol (2017) 0.75
History of the Use of Esophageal Stent in Management of Dysphagia and Its Improvement Over the Years. Dysphagia (2017) 0.75
Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med (2011) 16.93
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med (2004) 16.21
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology (2003) 9.36
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology (2002) 6.62
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med (2003) 4.12
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology (2006) 3.80
Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology (2007) 3.78
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. N Engl J Med (2005) 3.46
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology (2002) 3.29
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol (2005) 3.17
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology (2006) 3.14
Ectopic liver and hepatocarcinogenesis: report of three cases with four years' follow-up. Eur J Gastroenterol Hepatol (2004) 2.99
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology (2011) 2.86
Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst (2005) 2.51
Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology (2003) 2.44
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology (2004) 2.41
Endoscopic management of GI perforations with a new over-the-scope clip device (with videos). Gastrointest Endosc (2010) 2.38
Education improves colonoscopy appropriateness. Gastrointest Endosc (2007) 2.32
Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders. Scand J Gastroenterol (2014) 2.05
Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol (2010) 1.80
High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials. Hepatology (2012) 1.76
A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients. Gastroenterology (2005) 1.76
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab (2005) 1.73
Acute small bowel obstruction caused by endometriosis: a case report and review of the literature. World J Gastroenterol (2008) 1.72
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C. Hepatology (2009) 1.71
HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years. J Hepatol (2012) 1.69
Timing of precut procedure does not influence success rate and complications of ERCP procedure: a prospective randomized comparative study. Gastrointest Endosc (2009) 1.69
Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study. Am J Gastroenterol (2008) 1.69
Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants. Liver Transpl (2005) 1.68
AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers. J Hepatol (2007) 1.63
Lamivudine-resistant chronic hepatitis B: an observational study on adefovir in monotherapy or in combination with lamivudine. J Hepatol (2008) 1.60
Accuracy of narrow-band imaging in predicting colonoscopy surveillance intervals and histology of distal diminutive polyps: results from a multicenter, prospective trial. Gastrointest Endosc (2013) 1.58
Digestive endoscopy is not a major risk factor for transmitting hepatitis C virus. Ann Intern Med (2005) 1.55
Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine. Hepatology (2004) 1.52
Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study. Dig Liver Dis (2011) 1.52
EUS diagnosis and simultaneous endoscopic retrograde cholangiography treatment of common bile duct stones by using an oblique-viewing echoendoscope. Gastrointest Endosc (2006) 1.49
Successful closure of a postsurgical benign esophagomediastinal fistula by temporary placement of a polyester, expandable stent: Case report and review. Gastrointest Endosc (2002) 1.47
Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica (2007) 1.47
Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol (2006) 1.43
Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin. J Hepatol (2002) 1.43
Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study. Intern Emerg Med (2006) 1.41
Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes. Dis Colon Rectum (2009) 1.36
Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial. Scand J Gastroenterol (2008) 1.33
Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol (2003) 1.32
Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol (2005) 1.27
Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. Gastroenterology (2007) 1.24
Type 2 diabetes mellitus and chronic hepatitis C: which is worse? Results of a long-term retrospective cohort study. Dig Liver Dis (2012) 1.19
Ectopic livers and related pathology: report of three cases of benign lesions. Dig Dis Sci (2005) 1.19
Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance. Liver Transpl (2004) 1.14
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg (2006) 1.12
Capsule enteroscopy vs. other diagnostic procedures in diagnosing obscure gastrointestinal bleeding: a cost-effectiveness study. Eur J Gastroenterol Hepatol (2007) 1.11
Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl (2004) 1.10
Signal transducers and activators of transcription 3 signaling pathway: an essential mediator of inflammatory bowel disease and other forms of intestinal inflammation. Inflamm Bowel Dis (2005) 1.10
Appropriateness of colonoscopy: diagnostic yield and safety in guidelines. World J Gastroenterol (2007) 1.10
Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006). J Hepatol (2006) 1.09
Polyflex stents for malignant oesophageal and oesophagogastric stricture: a prospective, multicentric study. Eur J Gastroenterol Hepatol (2007) 1.08
Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. World J Gastroenterol (2004) 1.08
Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseases. World J Gastroenterol (2004) 1.08
Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Hepatology (2006) 1.08
Helicobacter species and liver diseases: association or causation? Lancet Infect Dis (2008) 1.08
On Helicobacter pylori eradication and migraine:what is the accuracy of the diagnostic method? Pain Physician (2013) 1.07
Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease? Am J Gastroenterol (2005) 1.06
Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence. Liver Transpl (2005) 1.06
Outcome of chronic delta hepatitis in Italy: a long-term cohort study. J Hepatol (2010) 1.06
Acute small-bowel perforation secondary to capsule endoscopy. Gastrointest Endosc (2007) 1.05
Lactic acidosis during Entecavir treatment in decompensated hepatitis B virus-related cirrhosis. Dig Liver Dis (2011) 1.04
Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis (2010) 1.02
Autoantibody signature in human ductal pancreatic adenocarcinoma. J Proteome Res (2007) 1.01
A meta-analysis of endoscopic stenting as bridge to surgery versus emergency surgery for left-sided colorectal cancer obstruction. Crit Rev Oncol Hematol (2013) 1.00
Consensus statement AIGO/SICCR: diagnosis and treatment of chronic constipation and obstructed defecation (part I: diagnosis). World J Gastroenterol (2012) 0.99
Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus. Hum Pathol (2008) 0.98
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. Liver Int (2011) 0.97
An update on HDV: virology, pathogenesis and treatment. Antivir Ther (2013) 0.97
Prevalence and prognostic value of hepatic histological alterations in patients with Crohn's disease. Scand J Gastroenterol (2015) 0.96
Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment). World J Gastroenterol (2012) 0.96
Alterations in colonic motility and relationship to pain in colonic diverticulosis. Clin Gastroenterol Hepatol (2005) 0.96
Fatal multiple systemic embolisms after injection of cyanoacrylate in bleeding gastric varices of a patient who was noncirrhotic but with idiopathic portal hypertension. Gastrointest Endosc (2006) 0.96
Safety and efficacy of endoscopic retrograde cholangiopancreatography in patients with post-liver transplant biliary complications: results of a cohort study with long-term follow-up. Gut Liver (2011) 0.96
Helicobacters and extragastric diseases. Helicobacter (2009) 0.95